Randall Kaye Biography and Net Worth

Randall E. Kaye is an Independent Director at NervGen Pharma Corp. since 2020 and the Chief Medical Officer & EVP at Longboard Pharmaceuticals, Inc. since 2022. Previously, he held positions as Vice President-Medical Affairs at Scios, Inc. from 2004 to 2006, Chief Medical Officer & SVP-Medical Affairs at Avanir Pharmaceuticals, Inc. from 2013 to 2014, Vice President-Medical Affairs at InterMune, Inc., Chief Medical Officer at Axsome Therapeutics, Inc. from 2014 to 2016, Chief Medical Officer at Click Therapeutics, Inc. from 2018 to 2019, Chief Scientific Officer at SSI Strategy LLC from 2014 to 2018, and Chief Medical Officer at Neurana Pharmaceuticals, Inc.

He obtained his undergraduate, graduate, and doctorate degrees from George Washington University.

What is Randall Kaye's net worth?: The estimated net worth of Randall Kaye is at least $1.07 million as of October 15th, 2024. Kaye owns 17,920 shares of Longboard Pharmaceuticals stock worth more than $1,074,842 as of March 12th. This net worth evaluation does not reflect any other investments that Kaye may own. Additionally, Kaye receives an annual salary of $717,950.00 as CMO at Longboard Pharmaceuticals. Learn More about Randall Kaye's net worth.
How old is Randall Kaye?: Kaye is currently 62 years old. There are 3 older executives and no younger executives at Longboard Pharmaceuticals. Learn More on Randall Kaye's age.
What is Randall Kaye's salary?: As the CMO of Longboard Pharmaceuticals, Inc., Kaye earns $717,950.00 per year. The highest earning executive at Longboard Pharmaceuticals is Mr. Kevin R. Lind, President, CEO, Secretary & Director, who commands a salary of $1,070,000.00 per year. Learn More on Randall Kaye's salary.
How do I contact Randall Kaye?: The corporate mailing address for Kaye and other Longboard Pharmaceuticals executives is 6154 NANCY RIDGE DRIVE, SAN DIEGO CA, 92121. Longboard Pharmaceuticals can also be reached via phone at 619-592-9775 and via email at ir@longboardpharma.com. Learn More on Randall Kaye's contact information.
Has Randall Kaye been buying or selling shares of Longboard Pharmaceuticals?: Randall Kaye has not been actively trading shares of Longboard Pharmaceuticals over the course of the past ninety days. Most recently, Randall Kaye sold 16,667 shares of the business's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $59.03, for a transaction totalling $983,853.01. Following the completion of the sale, the chief marketing officer now directly owns 17,920 shares of the company's stock, valued at $1,057,817.60. Learn More on Randall Kaye's trading history.
Are insiders buying or selling shares of Longboard Pharmaceuticals?: In the last twelve months, insiders at the sold shares 4 times. They sold a total of 50,100 shares worth more than $2,092,097.16. The most recent insider tranaction occured on October, 15th when CMO Randall Kaye sold 16,667 shares worth more than $983,853.01. Insiders at Longboard Pharmaceuticals own 4.6% of the company. Learn More about insider trades at Longboard Pharmaceuticals.
Information on this page was last updated on 10/15/2024.

Randall Kaye Insider Trading History at Longboard Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/15/2024	Sell	16,667	$59.03	$983,853.01	17,920
9/16/2024	Sell	16,666	$31.64	$527,312.24	17,920
8/12/2024	Sell	16,667	$34.73	$578,844.91	17,920
6/25/2024	Sell	100	$20.87	$2,087.00	17,920
1/23/2024	Buy	100	$24.82	$2,482.00	100

Randall Kaye Buying and Selling Activity at Longboard Pharmaceuticals

Longboard Pharmaceuticals Company Overview

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Today's Range

Now: $59.98

$59.98

$60.03

50 Day Range

MA: $59.88

$59.50

$59.98

2 Week Range

Now: $59.98

$15.64

$60.03

Volume

655,700 shs

Average Volume

924,556 shs

Market Capitalization

$2.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Randall Kaye Biography and Net Worth

What is Randall Kaye's net worth?

How old is Randall Kaye?

What is Randall Kaye's salary?

How do I contact Randall Kaye?

Has Randall Kaye been buying or selling shares of Longboard Pharmaceuticals?

Are insiders buying or selling shares of Longboard Pharmaceuticals?